Honeywell
HON
$223.26
-5.09%
Honeywell International Inc. is a global multi-industry conglomerate operating through four core segments: Aerospace Technologies, Industrial Automation, Energy and Sustainability Solutions, and Building Automation. The company is a market leader with one of the largest installed equipment bases globally, deriving significant recurring revenue from aftermarket services. The current investor narrative is dominated by the company's strategic portfolio transformation, including the planned spin-off of its Aerospace unit and the recent divestiture of its Productivity Solutions business, aimed at creating more focused entities and unlocking shareholder value amidst a backdrop of mixed quarterly financial performance.…
HON
Honeywell
$223.26
Related headlines
Investment Opinion: Should I buy HON Today?
Rating & Thesis: Hold. Honeywell is a compelling but fully-valued story stock where the anticipated benefits of its strategic transformation appear largely priced in, creating an asymmetric risk/reward profile skewed towards waiting for clearer execution signals. The bullish analyst sentiment and forward EPS estimate of $14.00 provide a ceiling, but near-term operational missteps warrant caution.
Supporting Evidence: The stock trades at a forward P/E of 20.76x, which is a premium to many industrial peers, justified by its high ROE (30.63%) and strong FCF generation ($5.393B TTM). However, this premium is challenged by recent fundamental weakness: Q4 revenue growth was -3.28% YoY, and gross margin compressed to 35.56%. The implied upside is contingent on a significant earnings recovery from the depressed Q4 EPS of $0.46 to the forward estimate of $14.00, a steep climb that embeds high expectations.
Risks & Conditions: The two biggest risks are failed execution of the portfolio transformation and a failure to reverse the Q4 margin compression. This Hold rating would upgrade to a Buy if the stock pulls back to a forward P/E near 18x (implying a price near $252 based on $14 EPS) on successful spin-off news, or if Q1 2026 results show a definitive rebound in revenue growth and margins above 36%. It would downgrade to a Sell if revenue growth remains negative for two consecutive quarters or if the forward P/E expands above 23x without corresponding fundamental improvement. Relative to its history and near-term fundamentals, the stock is currently fairly valued to slightly overvalued.
Sign up to view all
HON 12-Month Price Forecast
Honeywell presents a classic 'show me' story. The strategic rationale for its portfolio transformation is sound and has catalyzed recent outperformance, but the investment case now hinges entirely on execution to bridge the gap between premium valuation and recently soft fundamentals. The high ROE and FCF provide a solid foundation, but the probability-weighted outlook suggests limited near-term upside from current levels without clear evidence of a growth and margin rebound. The stance would upgrade to bullish on confirmation of successful spin-off execution and a return to positive organic revenue growth. It would turn bearish if the Q4 weakness proves not to be an anomaly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Honeywell's 12-month outlook, with a consensus price target around $290.24 and implied upside of +30.0% versus the current price.
Average Target
$290.24
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$179 - $290
Analyst target range
Analyst coverage for Honeywell is robust, with 9 analysts providing estimates. The consensus sentiment leans bullish, as evidenced by recent institutional ratings which include several 'Overweight' and 'Outperform' calls from firms like Barclays, RBC Capital, and JP Morgan, alongside 'Equal Weight' or 'Hold' ratings from others like Morgan Stanley and Jefferies. The average target price is not explicitly provided in the data, but analyst estimates focus on an average EPS of $14.00 for the forward period. The target price range is implied by the estimated revenue range of $45.99 billion to $47.59 billion and EPS range of $13.68 to $14.30. The high end of these estimates likely assumes successful execution of the aerospace spin-off, multiple expansion, and a rebound in growth and margins. The low end likely factors in potential integration issues, macroeconomic headwinds, or further margin pressure. The recent upgrade from Wolfe Research to 'Outperform' signals growing positive momentum among analysts. The spread between high and low estimates indicates a moderate level of uncertainty, typical for a company undergoing significant strategic change.
Bulls vs Bears: HON Investment Factors
The investment debate for Honeywell centers on the execution risk of its strategic transformation versus the potential for significant value unlocking. Currently, the bull side holds stronger evidence, driven by powerful catalysts (Aerospace spin-off), robust cash flow, and high ROE, which have fueled a recent 13% monthly rally. However, the bear case is substantiated by concerning near-term fundamentals, including a revenue miss, severe margin compression in Q4, and a premium valuation. The single most important tension is whether the company can successfully navigate its portfolio overhaul to reignite growth and expand margins, thereby justifying its elevated P/E multiple. If execution stumbles, the stock faces material downside from both multiple contraction and earnings disappointment.
Bullish
- Strong Portfolio Transformation Catalysts: The planned spin-off of the Aerospace unit and the recent $1.4B divestiture of the Productivity Solutions business are strategic moves aimed at unlocking shareholder value by creating more focused, higher-margin entities. This transformation is a key driver of the stock's 13.11% surge over the past month, as the market anticipates value creation.
- Robust Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $5.393 billion, providing ample internal funding for strategic initiatives, dividends, and debt service. This strong cash generation underpins the company's financial flexibility and supports its 2.39% dividend yield.
- High Return on Equity: Honeywell's Return on Equity (ROE) is an impressive 30.63%, indicating highly efficient use of shareholder capital. While amplified by leverage, this metric demonstrates the company's ability to generate significant profits from its equity base.
- Analyst Confidence in Forward Earnings: Analysts forecast forward EPS of approximately $14.00, a significant recovery from the depressed Q4 EPS of $0.46. The forward P/E of 20.76x, compared to the trailing P/E of 26.36x, implies the market is pricing in this expected earnings rebound.
Bearish
- Recent Revenue Miss and Weak Guidance: Q4 2025 revenue of $9.758B represented a -3.28% year-over-year decline, missing estimates. Recent news highlights investor anxiety over weak near-term guidance, overshadowing an earnings beat and raising concerns about the growth trajectory.
- Significant Q4 Profitability Compression: Q4 net income plummeted to $295M from $1.825B in Q3, with the net margin collapsing to 3.02% from 17.53%. Gross margin also compressed to 35.56% from the TTM average of 36.93%, indicating potential operational challenges or one-time impacts.
- Premium Valuation Relative to History: The trailing P/E of 26.36x sits above the stock's typical historical range (18x-23x), placing it at the higher end of its valuation band. This premium leaves the stock vulnerable to multiple compression if execution falters or growth disappoints.
- High Financial Leverage: A debt-to-equity ratio of 2.24 indicates a leveraged capital structure. While manageable given strong FCF, this leverage amplifies risks during economic downturns or periods of rising interest rates.
HON Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 12.07% one-year price change, but is currently consolidating after a significant rally. With a current price of $237.86, it is trading at approximately 96% of its 52-week high of $248.18, indicating it is near the top of its recent range and potentially facing technical resistance. The stock's 52-week low is $186.76, and its positioning near the highs suggests strong momentum but also raises the risk of a pullback if it fails to break through resistance. Recent momentum shows a strong rebound, with the stock up 13.11% over the past month, sharply reversing a -2.35% decline over the prior three months. This divergence from the short-term downtrend signals a potential resumption of the longer-term uptrend, driven by positive news flow around its strategic initiatives. The stock's beta of 0.811 indicates it is approximately 19% less volatile than the broader market (SPY), which is notable for a large-cap industrial, suggesting it may offer relative stability during market swings. Key technical support is anchored at the 52-week low of $186.76, while immediate resistance is at the 52-week high of $248.18. A decisive breakout above $248.18 would signal a continuation of the bullish trend, whereas a breakdown below the recent consolidation range could test lower support levels. The stock's maximum drawdown of -16.96% over the provided period highlights the magnitude of recent volatility, and its low beta suggests position sizing can be more aggressive relative to the market for a given level of risk tolerance.
Beta
0.81
0.81x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$187-$248
Price range past year
Annual Return
+4.5%
Cumulative gain past year
| Period | HON Return | S&P 500 |
|---|---|---|
| 1m | +6.5% | +5.0% |
| 3m | -6.3% | +10.7% |
| 6m | +16.7% | +10.0% |
| 1y | +4.5% | +26.5% |
| ytd | +14.0% | +10.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HON Fundamental Analysis
Revenue growth has been inconsistent, with the most recent Q4 2025 revenue of $9.758 billion representing a -3.28% year-over-year decline, continuing a trend of deceleration from stronger growth in earlier quarters of the fiscal year. Segment data shows Aerospace as the largest contributor at $8.692 billion, followed by Safety and Productivity Solutions at $4.747 billion and Home and Building Technologies at $3.663 billion, though the Productivity unit has since been divested. The revenue miss and weak guidance, as noted in recent news, are key concerns for the growth trajectory. The company remains profitable, with Q4 2025 net income of $295 million, but this represents a significant sequential drop from the $1.825 billion reported in Q3. The gross margin for Q4 was 35.56%, which is below the trailing twelve-month gross margin of 36.93% indicated in the valuation data, suggesting some margin compression in the most recent quarter. The net margin for the quarter was a thin 3.02%, a sharp contraction from the 17.53% net margin in Q3, indicating profitability was impacted by one-time items or operational challenges. Balance sheet health is mixed, with a strong current ratio of 1.32 indicating good short-term liquidity, but a high debt-to-equity ratio of 2.24 points to a leveraged capital structure. The company generates robust free cash flow, with TTM free cash flow of $5.393 billion, providing ample internal funding for growth initiatives, dividends, and debt service. The Return on Equity (ROE) is a very strong 30.63%, indicating efficient use of shareholder capital, though this is amplified by the high financial leverage.
Quarterly Revenue
$9.8B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.35%
Latest Quarter
Free Cash Flow
$5.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HON Overvalued?
Given the company's consistent profitability, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 26.36x, while the forward PE is lower at 20.76x. This gap implies the market expects earnings growth, with analysts forecasting forward EPS of approximately $14.00, up significantly from the most recent quarterly EPS of $0.46, which was depressed by one-time factors. Compared to industry averages, Honeywell's valuation presents a mixed picture. Its trailing PE of 26.36x is above the typical industrial conglomerate average (often in the low 20s), suggesting a premium. Its Price-to-Sales (PS) ratio of 3.33x and EV/EBITDA of 17.88x are also elevated relative to many industrials. This premium is likely justified by the company's high-margin aftermarket revenue stream, strong ROE, and the potential value-unlocking from its portfolio transformation, though near-term execution risks remain. Historically, the stock's current trailing PE of 26.36x sits above its own multi-year average seen in the historical ratios data, which has frequently ranged between 18x and 23x. This places the stock near the higher end of its historical valuation band, suggesting the market is pricing in optimistic expectations for the success of its strategic spin-offs and a return to stronger earnings growth. A reversion to the mean could pose a downside risk if execution falters.
PE
26.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~105x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Honeywell faces significant near-term financial risks, primarily stemming from its recent Q4 performance. Revenue declined -3.28% YoY, and net margin collapsed to 3.02% from 17.53% the prior quarter, indicating potential operational inefficiencies or one-time charges that may not be fully resolved. The company's high debt-to-equity ratio of 2.24, while supported by strong TTM free cash flow of $5.393B, creates vulnerability to rising interest rates and could constrain financial flexibility if cash generation weakens. Furthermore, the planned spin-off of the lucrative Aerospace segment, which contributed $8.692B in revenue, introduces execution and integration risks that could disrupt operations and dilute the remaining company's earnings profile.
Market & Competitive Risks: The stock's valuation presents a clear market risk. Its trailing P/E of 26.36x is above both typical industrial conglomerate averages and its own historical range, suggesting the market has priced in a successful transformation and earnings rebound. Any disappointment could trigger significant multiple compression. The stock's low beta of 0.811 offers relative stability but does not immunize it from sector-wide headwinds like an industrial slowdown. Competitive risks are heightened as the company refocuses; the divested Productivity unit was acquired by a competitor (Brady Corp), which is itself transforming into a high-growth AI-infrastructure play, illustrating dynamic competitive threats in Honeywell's end markets.
Worst-Case Scenario: The worst-case scenario involves a botched Aerospace spin-off that fails to unlock value, coupled with a continuation of the Q4 trend of revenue declines and margin pressure. This could lead to a cascade of analyst downgrades from the current bullish consensus, a derating of the P/E multiple back towards its historical mean of ~20x, and a test of the stock's 52-week low. Given the current price of $237.86 and the 52-week low of $186.76, a realistic downside in an adverse scenario is approximately -21% to that technical support level. A breach below that could see further declines, especially if the broader market enters a correction phase.
FAQ
The key risks are, in order of severity: 1) Execution Risk: The complex Aerospace spin-off could be delayed or fail to create the anticipated shareholder value. 2) Fundamental Deterioration: The Q4 trends of revenue decline (-3.28% YoY) and margin compression (gross margin to 35.56%) could persist. 3) Valuation Compression: The stock's premium P/E multiple (26.36x) could contract if growth disappoints, posing a -20%+ downside risk to its 52-week low. 4) Financial Leverage: The high debt-to-equity ratio of 2.24 increases sensitivity to interest rates and economic downturns.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $240 and $260, assuming the spin-off proceeds smoothly and earnings meet the $14.00 consensus. The Bull Case (30% probability) targets $270-$290 on flawless execution and multiple expansion. The Bear Case (20% probability) warns of a drop to $190-$210 if the transformation stumbles and fundamentals weaken. The most likely outcome is the Base Case, contingent on the company stabilizing its recent operational performance.
HON appears fairly valued to slightly overvalued based on near-term fundamentals. Its trailing P/E of 26.36x is above its own historical average and typical industrial conglomerate multiples, implying the market is paying a premium. This premium is justified by the company's high ROE (30.63%), strong free cash flow, and the potential value unlock from its portfolio transformation. However, this valuation embeds high expectations for a earnings recovery to a forward EPS of ~$14.00. If execution falters, the stock is vulnerable to multiple compression.
HON is a Hold, not a clear-cut buy at current levels. For investors who already own it, the strategic catalysts warrant maintaining the position. For new money, the risk/reward is balanced, with the stock trading at a premium valuation (26.36x trailing P/E) amidst recent fundamental weakness (-3.28% Q4 revenue growth). It could become a good buy on a pullback towards $210-$220, which would offer a better entry point to capture the upside from the Aerospace spin-off, or after the company demonstrates a clear quarter of operational improvement.
HON is more suitable for a medium to long-term investment horizon of 2-3 years. The value-unlocking thesis from its portfolio transformation is a multi-quarter process, and the stock's low beta (0.811) suggests it is not ideal for short-term trading based on volatility. Long-term investors can benefit from the strategic refocusing and the company's strong cash-generative business model. A minimum holding period through the completion of the Aerospace spin-off and at least two subsequent earnings reports is recommended to properly assess the execution of the new corporate strategy.